Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 18, 2019 16:01 ET | Source: Adaptimmune Therapeutics plc

Adaptimmune Announces Oral Presentation of Allogeneic SPEAR T-cell Program at 2019 ASGCT Meeting

- Presentation to include overview of substantial progress of Adaptimmune’s off-the-shelf SPEAR T-cell platform - - Data will show that hiPSC-derived allogeneic SPEAR T-cells have a T-cell phenotype...
April 18, 2019 08:00 ET | Source: Geron Corporation

Geron Expands Senior Leadership of Its Development Team

MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced an expansion of its development team’s senior leadership with the addition of three highly...
April 17, 2019 16:45 ET | Source: AquaBounty Technologies, Inc.

AquaBounty Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares

MAYNARD, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a biotechnology company focused on enhancing productivity in the...
April 17, 2019 08:05 ET | Source: Organovo, Inc.

Organovo to Present at 2019 Cell & Gene Meeting on the Mediterranean

SAN DIEGO, April 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a...
April 17, 2019 08:00 ET | Source: Radius Health Inc.

Radius Health to Present Two Posters at AACE 2019 Annual Meeting

WALTHAM, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing...
April 17, 2019 08:00 ET | Source: LifeVantage Corporation

LifeVantage to Announce Third Quarter Fiscal Year 2019 Results on May 1, 2019

SALT LAKE CITY, April 17, 2019 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its third quarter ended March 31, 2019, after the...
April 17, 2019 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Named to Forbes 2019 List of America's Best Midsize Employers and the Women Tech Council’s 2019 Shatter List

SALT LAKE CITY, April 17, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced today announced that the company was named to...
April 16, 2019 16:00 ET | Source: Adverum Biotechnologies, Inc.

Adverum Biotechnologies to Present New Preclinical Data on ADVM-022 Gene Therapy for Wet AMD at ASGCT and ARVO

MENLO PARK, Calif., April 16, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases,...
April 16, 2019 08:00 ET | Source: Seelos Therapeutics, Inc.

Seelos Therapeutics to Participate at the Jefferies 2019 Global Healthcare Conference in NYC

NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, announced today that they will present and host 1x1 and small group...
April 15, 2019 16:15 ET | Source: Cryo-Cell International, Inc.

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2019 Financial Results

OLDSMAR, Fla., April 15, 2019 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store...